Narayana Hrudayalaya Ltd. has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release for the quarter ended December 31, 2025.".
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Narayana Hrudayalaya reported its highest-ever consolidated quarterly revenue of ₹21,512 Mn for Q3 FY26, up 61.2% year-on-year, driven by strong growth across India, Cayman, and a new UK business. Adjusted EBITDA rose to ₹4,662 Mn (margin 21.7%) and adjusted PAT grew 31.6% YoY to ₹2,548 Mn. However, reported PAT fell 33.9% to ₹1,281 Mn due to one-time costs of ₹757 Mn for the UK acquisition and ₹509 Mn from a new labour code. India revenue grew 11.8% YoY to ₹11,796 Mn (but dipped 4.5% QoQ), Cayman revenue surged 70% YoY to ₹4,991 Mn, and UK contributed ₹4,902 Mn since the November 6, 2025 acquisition of Practice Plus Group Hospitals. Net debt-to-equity stood at 0.53, including foreign currency borrowings of US$119 Mn and GBP£150 Mn. Management remains confident of meeting full-year expectations and will host a conference call on February 17, 2026.
Strong top-line growth from international expansion, especially the new UK operations, signals the company's global growth strategy is paying off, but margin compression and one-time charges weighed on bottom-line growth. Shareholders may view the UK acquisition positively for long-term growth, though near-term margins and QoQ India softness could be near-term concerns.